The study enrolled 3,414 children under the age of 5 with acute respiratory infection in Belgium, Italy, the Netherlands, Spain, and the United Kingdom (UK), of which 33% tested positive for RSV ...

A prominent paediatrician on Sunday urged people to take more precautions against a common virus known as RSV, saying cases ...

Estimates varied from 2008 through 2018, with RSV-associated antibiotic prescribing exceeding 10% in peak RSV years and ...

The study enrolled 3,414 children under the age of 5 with acute respiratory infection in Belgium, Italy, the Netherlands, Spain, and the United Kingdom (UK), of which 33% tested positive for RSV ...

It starts with a sniffle. A mild cough. You tell yourself it’s just a cold—babies get those, right? But make no mistake. RSV ...

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug ...

Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...

The Food and Drug Administration (FDA) has approved Enflonsia ™ (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who ...

Each year, on November 12, we observe World Pneumonia Day to raise awareness about one of the most serious and often ...

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated ...

Respiratory syncytial virus (RSV) causes millions of childhood illnesses yearly, particularly in poorer countries. On 30 May 2025, the World Health Organisation issued its first global guidance ...